Tesaro: on the up. Rumoured interest from Sanofi.
(CercleFinance.com) - American biotech firm Tesaro has seen its share shoot up by more than 4% on Wall Street yesterday.
It seems that it is being eyed up not only by biopharma group Gilead Sciences, as rumour would have it since the beginning of the year, but also by French company Sanofi, according to StreetInsider.com.
The American financial news publication believes that an offer that could value Tesaro at some ten billion dollars, so approximately 185 dollars per share, is currently being looked at, although its current market capitalisation stands at 8.2 billion.
StreetInsider.com also reports that an acquisition deal for Tesaro could be announced over the next few weeks.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
It seems that it is being eyed up not only by biopharma group Gilead Sciences, as rumour would have it since the beginning of the year, but also by French company Sanofi, according to StreetInsider.com.
The American financial news publication believes that an offer that could value Tesaro at some ten billion dollars, so approximately 185 dollars per share, is currently being looked at, although its current market capitalisation stands at 8.2 billion.
StreetInsider.com also reports that an acquisition deal for Tesaro could be announced over the next few weeks.
Copyright (c) 2017 CercleFinance.com. All rights reserved.